CEL-SCI Corporation Provides Update on Phase III Clinical Trial

Published April 23, 2013

CEL-SCI Corporation Provides Update on Phase III Clinical Trial
Filed under: cocaine treatment h1n1
CEL-SCI Corporation (NYSE MKT: CVM) today provided an update on the Phase III Clinical Trial of its investigational drug Multikine* (Leukocyte Interleukin, Injection) for the treatment of head and neck cancer. The Company announced that it … global … Read more on The Herald | HeraldOnline.com

Recreational Marijuana Users More Likely To Misuse Prescription Drugs …
Filed under: cocaine treatment h1n1
The study also found that while marijuana was the most frequently abused drug of patients tested, individuals who used prescribed marijuana (prescription cannabinoids) were not more likely to misuse other drugs than non-marijuana users. … the most … Read more on MarketWatch (press release)